News

Video

AAO 2024: Approaching pregnant women across the ophthalmic subspecialties

Author(s):

Key Takeaways

  • Dr. Arepalli emphasized the need for better treatment protocols for ocular conditions in pregnant patients, particularly in retina and uveitis.
  • Lack of established guidelines for managing these conditions poses risks for both mother and fetus.
SHOW MORE

Dr. Arepalli discussed a course focused on ocular conditions related to pregnancy and postpartum care, presented at the American Academy of Ophthalmology (AAO) meeting.

In a recent discussion with Dr. Arepalli and Sydney Crago from Modern Retina and Ophthalmology Times discussed a course focused on ocular conditions related to pregnancy and postpartum care, presented at the American Academy of Ophthalmology (AAO) meeting. Dr. Arepalli emphasized the need for better understanding and treatment protocols for conditions affecting pregnant patients, particularly in the fields of retina and uveitis.

She highlighted the lack of established guidelines for managing these conditions due to the risks involved for both the mother and fetus. Dr. Arepalli collaborated with colleagues from various ophthalmologic subspecialties, including neuro-ophthalmology, oncology, and glaucoma, to address common ocular conditions encountered during pregnancy. Key topics include diabetic retinopathy and diabetic macular edema, both of which require careful management due to the potential for long-term vision loss if left untreated.

The discussion also touched on the complexities of treating pregnant patients with retinal detachment, where timely surgical intervention is critical but necessitates collaboration with obstetricians and anesthesiologists. Additionally, Dr. Arepalli noted that gestational diabetes can complicate the management of diabetic eye conditions, presenting challenges for both patients and healthcare providers.

She expressed enthusiasm for the AAO meeting, which brings together experts to share insights and treatment strategies, hoping that attendees will gain valuable knowledge from the course. Dr. Arepalli's course aims to equip ophthalmologists with the tools necessary to address the unique challenges of treating ocular conditions in pregnant patients, ultimately improving patient care and outcomes.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.